The refinement of the super generic concept: semantic challenge for product re-innovation?

Author(s): Fereshteh Barei, PhD, Malcolm Ross

Background: Uptake of super generic or hybrid pharmaceuticals has decelerated despite their important economic potential for the generic pharmaceutical industry. The aim of switching to these product portfolios was to enable product differentiation; however, these strategies are influenced by new semantic challenges, which have hampered the promotion of value-added pharmaceuticals or super generics in recent […]

Read more →